The Preterm Infant: A High-Risk Situation for Neonatal Hyperbilirubinemia Due to Glucose-6-Phosphate Dehydrogenase

Michael Kaplan1, Cathy Hammerman1, Vinod K Bhutani2

  • 1Faculty of Medicine, The Hebrew University of Jerusalem, Ein Kerem, P.O. Box 12271, Jerusalem, 9112102 Israel; Department of Neonatology, Shaare Zedek Medical Center, PO Box 3235, Jerusalem 91031, Israel.

Insights

Prematurity and glucose-6-phosphate dehydrogenase (G6PD) deficiency increase the risk of severe neonatal jaundice. Vigilant observation for jaundice in preterm infants with G6PD deficiency is crucial to prevent potential brain damage.

Area of Science:

  • Neonatology
  • Hematology
  • Genetics

Background:

  • Prematurity and glucose-6-phosphate dehydrogenase (G6PD) deficiency are significant risk factors for neonatal hyperbilirubinemia.
  • These conditions can interact, leading to severe hyperbilirubinemia and potential bilirubin neurotoxicity.
  • Neonatal jaundice in these infants results from acute hemolysis and immature bilirubin conjugation.

Purpose of the Study:

  • To highlight the combined risks of prematurity and G6PD deficiency in neonatal hyperbilirubinemia.
  • To emphasize the unpredictable nature of hemolysis in G6PD-deficient infants.
  • To underscore the importance of monitoring preterm infants with G6PD deficiency for jaundice.

Main Methods:

  • Literature review on prematurity, G6PD deficiency, and neonatal hyperbilirubinemia.
  • Analysis of the pathophysiological mechanisms of hyperbilirubinemia in affected neonates.
  • Clinical observation and risk assessment strategies.

Main Results:

  • Combined prematurity and G6PD deficiency pose a substantial risk for extreme neonatal jaundice.
  • Hemolysis episodes can be sudden and unpredictable, exacerbated by immature bilirubin conjugation.
  • Preventing known triggers reduces but does not eliminate hemolysis risk.

Conclusions:

  • Preterm infants with G6PD deficiency require close monitoring for jaundice, both in-hospital and post-discharge.
  • Early detection and management are essential to prevent bilirubin neurotoxicity.
  • Awareness of interacting risk factors is critical for neonatal care.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
995
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
315
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.1K
Other Glycolytic Pathways01:24

Other Glycolytic Pathways

The pentose phosphate pathway (PPP) operates in parallel with glycolysis, facilitating the metabolism of both pentoses and glucose. This pathway consists of two distinct phases: the oxidative and non-oxidative phases. While it does not directly generate ATP, the intermediates formed during the process can integrate into glycolysis, contributing to cellular energy metabolism when required.Oxidative Phase: NADPH ProductionThe oxidative phase of the pentose phosphate pathway is primarily...
1.1K